Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
58 participants
OBSERVATIONAL
2024-01-01
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These patients are currently at a therapeutic impasse. This strategy of renal transplantation on an iliac artery endoprosthesis could ultimately give them access to the transplant with an improvement in quality of life and survival, for lower costs of care for the hospital and safety. less social than treatment by hemodialysis
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a New Regional Organization to Promote Access to Renal Transplantation
NCT03234075
A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis
NCT03477071
Impact of Preemptive Living Donor Renal Transplantation on Quality of Life , Occupational Rehabilitation and Societal Participation of Transplant Recipients
NCT02893475
A Simple Clinical Tool for Increasing Enrollment on a Kidney Transplant Waiting List for Patients Aged Over 70 and Initiating Dialysis
NCT02746146
Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients.
NCT03764124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single group of adult patients with chronic renal failure who are all awaiting a kidney transplant
This study focuses on a single group of adult patients with chronic renal failure who are all awaiting a kidney transplant, whether or not they are treated by extra-renal purification.
These patients are contraindicated for transplantation due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses and They can only receive the kidney transplant after arterial preparation.
This is an observational and retrospective study
It concerns all patients with chronic renal failure awaiting a kidney transplant, and presenting a contraindication to the transplant due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses. They can only receive the kidney transplant after arterial preparation. These patients will be included and will benefit from endovascular preparation for the kidney transplant using a tailor-made arterial stent.
Imaging examinations and follow-up clinical data will be analyzed. Reinterventions and causes of death will be analyzed.
An information sheet will be given to patients; if the patient refuses the use of their data, it will not be collected.
Data collection will be carried out by ARCs or PIs of the centers from medical records. The data will be pseudo-anonymized, entered into a REDCAP database shared between each center.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This is an observational and retrospective study
It concerns all patients with chronic renal failure awaiting a kidney transplant, and presenting a contraindication to the transplant due to their anatomical constraints: major arterial calcifications, iliac dissections, iliac stenoses. They can only receive the kidney transplant after arterial preparation. These patients will be included and will benefit from endovascular preparation for the kidney transplant using a tailor-made arterial stent.
Imaging examinations and follow-up clinical data will be analyzed. Reinterventions and causes of death will be analyzed.
An information sheet will be given to patients; if the patient refuses the use of their data, it will not be collected.
Data collection will be carried out by ARCs or PIs of the centers from medical records. The data will be pseudo-anonymized, entered into a REDCAP database shared between each center.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with chronic renal failure
3. Waiting for a kidney transplant
4. Who have a vascular contraindication to renal transplantation because of their anatomical constraints.
Exclusion Criteria
* A progressive cancer, which is not cured,
* An uncontrolled infectious disease,
* Severe cardiovascular or respiratory disease making general anesthesia impossible,
* Unstabilized psychiatric disorders or illness,
* Dementia proven to have progressed after specialist advice
* Major obesity, with a body mass index greater than 50 kg/m2
* Patient refusal 2. Patient under curatorship 3. Pregnant woman 4. Patients for whom it will not be possible to organize regular medical follow-up
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HCL Hopital Louis Pradel
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stephan HAULON
Role: backup
Xavier BERARD
Role: backup
Xavier CHAUFFOUR
Role: backup
Didier PLISSONIER
Role: backup
Fabien THAVEAU
Role: backup
Eric STEINMETZ
Role: backup
Jean-Marc ALSAC
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_5431
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.